Bandingkan dokter dan harga Kemoterapi Intraperitoneal Hipertermik (HIPEC) teratas di Israel. Temukan pencocokan terbaik Anda di sini.
Kami akan memilih dokter terbaik berdasarkan kebutuhan dan anggaran Anda.
Ditinjau secara medis oleh Fahad Mawlood
Editor Medis & Data ScientistDokter teratas
12
Israel
Ulasan
14000+
Dari pasien asli
Bandingkan harga untuk Kemoterapi Intraperitoneal Hipertermik (HIPEC) di negara-negara teratas
Ketuk negara untuk melihat dokter teratas dan harga
Dapatkan rencana perawatan yang dipersonalisasi gratis dan pilih opsi terbaik. Tanpa komitmen · Tidak ada pembayaran untuk layanan kami
Tampilkan pertama:
Dr. Pelles Sharon berspesialisasi dalam HIPEC di Sourasky Medical Center, membawa keahlian luas dalam perawatan kanker tingkat lanjut.
Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center, yang berspesialisasi dalam perawatan kanker yang kompleks.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.
MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.
Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.
Kepala Divisi Onkologi Medis di Sourasky Medical Center – Dr. Wolf memimpin tim terkemuka yang berspesialisasi dalam pengobatan kanker tingkat lanjut.
Pemimpin Inisiatif Kedokteran Genomik Nasional Israel – Dr. Raphael berspesialisasi dalam onkologi presisi di Sourasky Medical Center.
Dr. Ron Greenberg mengepalai Departemen Bedah Kolorektal di Sourasky Medical Center, berspesialisasi dalam operasi abdomen dengan pengalaman lebih dari 20 tahun.
Dengan pengalaman bedah lebih dari 45 tahun – Dr. Klauzner adalah Ketua Bedah di Sourasky Medical Center dan berspesialisasi dalam prosedur gastrointestinal.
Dr. Auala Hubert memimpin Pusat Kanker Gastrointestinal di Hadassah Medical Center, berspesialisasi dalam HIPEC dengan 33 tahun pengalaman di bidang onkologi.
Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.
He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.
He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.
Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.
He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.
Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.
Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.
He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.
He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.
Memilih klinik di luar negeri bisa membuat stres. Di Bookimed, dengan 800.000+ pasien telah dibantu, kami memahami kekhawatiran Anda. Kami tahu cara menemukan dokter terpercaya, opsi harga terbaik, dan solusi bahkan untuk kasus yang rumit. Kami siap membimbing Anda di setiap langkah.
Yan Matsiivskiy
Kepala Tim Koordinator Medis
4300++ perjalanan pasien yang dipandu
3 tahun di Bookimed
142 pasien dari Israel telah menemukan dokternya melalui kami bulan ini
Kuis 2 menit
Ceritakan tujuan, anggaran, dan waktu Anda
Pencocokan Manusia + AI
Algoritme kami menemukan kecocokan, koordinator memverifikasi kesesuaian
Pilihan Anda Siap
Bandingkan harga, paket, tanggal. Chat dengan koordinator Anda
Bingung dengan banyak pilihan?
Membimbing pengobatan Anda
Koordinator pribadi berpengalaman medis
| Peringkat | Dokter | pengalaman | Cocok Untuk | Apa yang Membedakan Mereka | Klinik & Lokasi | Konsultasi |
|---|---|---|---|---|---|---|
| #1 | 23 tahun pengalaman | Kanker peritoneum tingkat lanjut | Berspesialisasi dalam HIPEC dengan fokus pada rencana perawatan yang dipersonalisasi. Melakukan penelitian klinis untuk memajukan terapi kanker. | Israel | dari $825 | |
| #2 | 41 tahun pengalaman | Kas-kas sarkoma kompleks | Berspesialisasi dalam sarkoma jaringan lunak dan tulang – pelatihan di Institut Gustave Roussy. Anggota fakultas kelompok Sarkoma ESMO. | Israel | dari $950 | |
| #3 | 34 tahun pengalaman | Kanker peritoneum lanjut | Memimpin Divisi Onkologi Medis yang ternama dengan keahlian dalam penanganan kasus kanker yang kompleks. Menggabungkan pengalaman medis klinis dan militer untuk strategi perawatan pasien yang kuat. | Israel | Harga berdasarkan permintaan | |
| #4 | 29 tahun pengalaman | Pendekatan onkologi presisi | Pelopor profil genomik untuk seleksi pasien HIPEC. Memimpin inisiatif kedokteran genomik nasional dan berbagai uji coba imunoterapi. Anggota ESMO/IASLC dengan fokus toraks. | Israel | dari $750 | |
| #5 | 35 tahun pengalaman | Operasi perut kompleks | Kepala departemen dengan keahlian ekstensif dalam prosedur abdomen, baik yang terbuka maupun minimal invasif, termasuk operasi Whipple. | Israel | Harga berdasarkan permintaan | |
| #6 | 42 tahun pengalaman | Bedah kolorektal dan pankreas | Ahli bedah Whipple terkemuka di Israel dengan fokus pada prosedur gastrointestinal. Ketua Bedah di Sourasky Medical Center. | Israel | Harga berdasarkan permintaan | |
| #7 | 36 tahun pengalaman | Kasus kanker gastrointestinal | Kepala Pusat Kanker Gastrointestinal di Hadassah. Bersertifikasi dewan (Board-certified) dalam onkologi dan radioterapi. Anggota komite kanker utama Israel. | Israel | Harga berdasarkan permintaan |
Leading HIPEC surgeons in Israel include Dr. Pelles Sharon and Dr. Joseph Klauzner at Sourasky Medical Center. These specialists focus on complex cytoreductive surgery combined with heated chemotherapy. They hold senior leadership roles and maintain international certifications from organizations like ESMO and the European Society of Surgical Oncology.
Bookimed Expert Insight: A distinct pattern among top Israeli HIPEC specialists is the integration of genomic profiling. For instance, Dr. Ari Raphael at Sourasky Medical Center leads the National Genomic Medicine Initiative. This allows teams to use precise genomic data to select the most effective chemotherapy perfusate for each patient before the 10-12 hour procedure begins.
Patient Consensus: Patients emphasize that achieving complete tumor debulking before the chemotherapy wash is life-changing. Many survivors noted that the recovery in the ICU is grueling but felt the precision of the surgical teams led to fewer recurrences. They highlight that Israeli centers often tailor chemo mixes specifically for rare conditions like pseudomyxoma peritonei.
Israeli HIPEC doctors are surgical oncologists who typically undergo a six-year general surgery residency followed by advanced fellowships in peritoneal surface oncology. Many specialists complete international training at centers in the USA, France, or Italy to master complex cytoreductive techniques.
Bookimed Expert Insight: Data shows that top Israeli surgeons often hold dual roles as clinical leaders and national policy chairs. For example, Dr. Joseph Klauzner at Sourasky Medical Center has over 45 years of experience and chairs the National Council on Surgery. This combination of decades-long practice and leadership in national surgical protocols ensures patients receive care from recognized authorities in abdominal oncology.
Patient Consensus: Patients often mention feeling confident because their surgeons gained extra trauma experience during military medical service. They note that doctors here perform many procedures annually, which makes the complex process feel more routine. People also appreciate that many specialists, like Dr. Auala Hubert, speak fluent English for easy communication.
During the heated chemotherapy phase, the surgical oncologist manages the chemo bath to target microscopic cancer cells. They insert specialized catheters, monitor the solution temperature at 108°F, and manually distribute the drugs. This active management by the surgeon is critical for effective peritoneal cancer treatment.
Bookimed Expert Insight: Data shows that in Israel, HIPEC is often led by surgeons with dual expertise in oncology and complex gastrointestinal procedures. For example, Dr. Joseph Klauzner at Sourasky Medical Center has 45+ years of experience in abdominal oncology. This depth of experience allows surgeons to adjust the heated perfusion time based on real-time tumor burden observations.
Patient Consensus: Patients notice that the surgeon stays at the table for the entire 90-minute infusion. They feel reassured knowing the doctor is actively sloshing the solution to coat every area. It is a relief to see the intensive monitoring used to keep their body temperature stable.
Leading Israeli HIPEC doctors offer remote consultations to help international patients plan complex abdominal cancer treatments. These virtual sessions include medical record reviews and surgical eligibility assessments. Top specialists at JCI-accredited centers typically provide these services via video platforms to streamline the pre-travel process.
Bookimed Expert Insight: Data shows a clear trend where top-tier Israeli surgeons, such as those at Sourasky Medical Center (Ichilov), offer virtual consultations starting from $750 to $950. While surgical costs for HIPEC range from $61,200 to $95,900, these remote sessions allow patients to confirm their candidacy before investing in travel. This specialized access is particularly valuable for patients seeking surgeons with international training from institutions like the Royal Marsden in London.
Patient Consensus: Patients note that Israeli surgical teams are very responsive to overseas inquiries via video calls. Many were surprised by how quickly doctors reviewed their CT scans remotely to approve them for travel. While some say an in-person visit is still required for the final diagnosis, they feel much more prepared having a plan before they fly.
Israeli surgeons perform HIPEC primarily through open surgery to treat advanced peritoneal cancers. While laparoscopic HIPEC is globally rare, specialists like Dr. Pelles Sharon at Sourasky Medical Center provide targeted HIPEC treatments. Most procedures focus on maximizing tumor removal through proven traditional methods at JCI-accredited hospitals.
Bookimed Expert Insight: Data shows a strong trend toward multidisciplinary care where surgeons and oncologists collaborate closely. For example, Dr. Pelles Sharon and Professor Ofer Merimsky work within the same highly-rated Tel Aviv facility. Consultations with these specialists range from $750 to $950, reflecting their high level of international training and academic leadership.
Patient Consensus: Patients note that while they initially looked for minimally invasive options, they felt more confident in the thorough results of open surgery. Many were surprised by how quickly they recovered after treatment for appendiceal or colorectal cancers. They emphasize focusing on the surgeon's experience with the HIPEC procedure itself rather than the specific entry technique.